These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16794749)

  • 1. The presence of necrosis and/or microvascular proliferation does not influence survival of patients with anaplastic oligodendroglial tumours: review of 98 patients.
    Smith SF; Simpson JM; Brewer JA; Sekhon LH; Biggs MT; Cook RJ; Little NS
    J Neurooncol; 2006 Oct; 80(1):75-82. PubMed ID: 16794749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of oligodendroglial tumors based on histopathology criteria is a significant predictor of survival--clinical, radiological and pathologic long-term follow-up analysis.
    Sepulveda Sanchez JM; Martinez Montero JC; Diez-Lobato R; Hernandez-Lain A; Cabello A; Ramos A; Gonzalez Leon P; Ricoy Campo JR
    Clin Neuropathol; 2009; 28(1):11-20. PubMed ID: 19216215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.
    Miller CR; Dunham CP; Scheithauer BW; Perry A
    J Clin Oncol; 2006 Dec; 24(34):5419-26. PubMed ID: 17135643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathology of oligodendroglial tumors.
    Hartmann C; von Deimling A
    Recent Results Cancer Res; 2009; 171():25-49. PubMed ID: 19322536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing incidence and improved survival of gliomas.
    Ho VK; Reijneveld JC; Enting RH; Bienfait HP; Robe P; Baumert BG; Visser O;
    Eur J Cancer; 2014 Sep; 50(13):2309-18. PubMed ID: 24972545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implication of histological oligodendroglial tumor component: clinicopathological analysis of 111 cases of malignant gliomas.
    Kanno H; Nishihara H; Narita T; Yamaguchi S; Kobayashi H; Tanino M; Kimura T; Terasaka S; Tanaka S
    PLoS One; 2012; 7(7):e41669. PubMed ID: 22911839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotrophin expression in astrocytic and oligodendroglial tumors and it's correlation with histological diagnosis, microvascular density, cellular proliferation and overall survival.
    Peria FM; Neder L; Marie SK; Rosemberg S; Oba-Shinjo SM; Colli BO; Gabbai AA; Malheiros SM; Zago MA; Panepucci RA; Moreira-Filho CA; Okamoto OK; Carlotti CG
    J Neurooncol; 2007 Sep; 84(3):255-61. PubMed ID: 17443289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.
    Sunwoo L; Choi SH; Yoo RE; Kang KM; Yun TJ; Kim TM; Lee SH; Park CK; Kim JH; Park SW; Sohn CH; Won JK; Park SH; Kim IH
    Neuroradiology; 2015 Nov; 57(11):1111-20. PubMed ID: 26232204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.
    Gorlia T; Delattre JY; Brandes AA; Kros JM; Taphoorn MJ; Kouwenhoven MC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ
    Eur J Cancer; 2013 Nov; 49(16):3477-85. PubMed ID: 23896377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
    Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors.
    Panageas KS; Reiner AS; Iwamoto FM; Cloughesy TF; Aldape KD; Rivera AL; Eichler AF; Louis DN; Paleologos NA; Fisher BJ; Ashby LS; Cairncross JG; Urgoiti GB; Wen PY; Ligon KL; Schiff D; Robins HI; Rocque BG; Chamberlain MC; Mason WP; Weaver SA; Green RM; Kamar FG; Abrey LE; DeAngelis LM; Jhanwar SC; Rosenblum MK; Lassman AB
    Neuro Oncol; 2014 Nov; 16(11):1541-6. PubMed ID: 24997140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seizures in patients with supratentorial oligodendroglial tumours. Clinicopathological features and management considerations.
    Whittle IR; Beaumont A
    Acta Neurochir (Wien); 1995; 135(1-2):19-24. PubMed ID: 8748787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic study of methionine positron emission tomography in patients with glioblastoma with oligodendroglial components.
    Yano H; Ohe N; Nakayama N; Nomura Y; Miwa K; Shinoda J; Iwama T
    Brain Tumor Pathol; 2015 Oct; 32(4):253-60. PubMed ID: 25812514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicohistological study of oligodendroglioma and oligoastrocytoma.
    Tamura M; Zama A; Kurihara H; Kano T; Imai H; Ishiuchi S; Iwai T; Naito I
    Brain Tumor Pathol; 1997; 14(1):35-9. PubMed ID: 9384800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas.
    Tortosa A; Viñolas N; Villà S; Verger E; Gil JM; Brell M; Caral L; Pujol T; Acebes JJ; Ribalta T; Ferrer I; Graus F
    Cancer; 2003 Feb; 97(4):1063-71. PubMed ID: 12569607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Postoperative radiotherapy of supratentorial anaplastic glioma].
    Wendt TG; Bacherler B; Baumer K; Rohloff R; Willich N
    Strahlenther Onkol; 1986 Jun; 162(6):347-53. PubMed ID: 3738736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High grade glioma: imaging combined with pathological grade defines management and predicts prognosis.
    Burnet NG; Lynch AG; Jefferies SJ; Price SJ; Jones PH; Antoun NM; Xuereb JH; Pohl U
    Radiother Oncol; 2007 Dec; 85(3):371-8. PubMed ID: 18035440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma with oligodendroglial components: glioblastoma or anaplastic oligodendroglial tumors.
    Takeuchi H; Hosoda T; Kitai R; Kodera T; Arishima H; Tsunetoshi K; Neishi H; Yamauchi T; Sato K; Imamura Y; Itoh H; Kubota T; Kikuta K
    Brain Tumor Pathol; 2012 Jul; 29(3):154-9. PubMed ID: 22527749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach.
    Rajmohan KS; Sugur HS; Shwetha SD; Ramesh A; Thennarasu K; Pandey P; Arivazhagan A; Santosh V
    J Clin Pathol; 2016 Aug; 69(8):686-94. PubMed ID: 26743027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.